methazolamide and dichlorphenamide
methazolamide has been researched along with dichlorphenamide in 128 studies
Research
Studies (128)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (9.38) | 18.7374 |
1990's | 2 (1.56) | 18.2507 |
2000's | 73 (57.03) | 29.6817 |
2010's | 41 (32.03) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Anderson, PS; Baldwin, JJ; Best, DB; Christy, ME; Freedman, MB; Gautheron, P; Graham, SL; Habecker, CN; Hoffman, JM; Shepard, KL | 1 |
Bicking, JB; Brown, SL; deSolms, SJ; Fishman, DR; Gautheron, PD; Graham, SL; Hoffman, JM; Larson, RD; Schwam, H; Woltersdorf, OW | 1 |
Briganti, F; Menabuoni, L; Mincione, F; Mincione, G; Scozzafava, A; Supuran, CT | 1 |
Casini, A; Ilies, MA; Menabuoni, L; Mincione, F; Scozzafava, A; Supuran, CT | 1 |
Menabuoni, L; Mincione, F; Scozzafava, A; Supuran, CT | 1 |
Scozzafava, A; Supuran, CT | 2 |
Grüneberg, S; Klebe, G; Stubbs, MT | 1 |
Casini, A; Montero, JL; Scozzafava, A; Supuran, CT; Winum, JY | 1 |
Abbate, F; Antel, J; Casini, A; David, S; Schäfer, S; Scozzafava, A; Supuran, CT; Waldeck, H | 1 |
Franchi, M; Gallori, E; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Caproiu, MT; Ilies, M; Ilies, MA; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Casini, A; Mincione, F; Montero, JL; Scozzafava, A; Starnotti, M; Supuran, CT; Winum, JY | 1 |
Abbate, F; Casini, A; Ciattini, S; Coetzee, A; Scozzafava, A; Supuran, CT | 1 |
Casini, A; Heine, A; Klebe, G; Kuhn, D; Scozzafava, A; Supuran, CT; Weber, A | 1 |
Antel, J; Franchi, M; Gallori, E; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Casini, A; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Casey, JR; Mastrolorenzo, A; Morgan, PE; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Casini, A; de Leval, X; Dogné, JM; Ilies, M; Masini, E; Mincione, F; Scozzafava, A; Starnotti, M; Supuran, CT | 1 |
Jaiswal, M; Khadikar, PV; Scozzafava, A; Supuran, CT | 1 |
Casini, A; Lehtonen, JM; Parkkila, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Fasolis, G; Garaj, V; Innocenti, A; Montero, JL; Puccetti, L; Scozzafava, A; Supuran, CT; Vullo, D; Winum, JY | 2 |
Alcaro, MC; Casini, A; Innocenti, A; Papini, AM; Scozzafava, A; Supuran, CT | 1 |
Cecchi, A; Innocenti, A; Montero, JL; Scozzafava, A; Supuran, CT; Vullo, D; Winum, JY | 1 |
Casini, A; Ferry, JG; Innocenti, A; Scozzafava, A; Supuran, CT; Zimmerman, S | 1 |
Durgun, M; Emul, M; Innocenti, A; Scozzafava, A; Supuran, CT; Turkmen, H; Vullo, D; Yilmaztekin, S | 1 |
Innocenti, A; Jakubickova, L; Montero, JL; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D; Winum, JY | 1 |
Innocenti, A; Nishimori, I; Pastorek, J; Pastoreková, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Innocenti, A; Kaila, K; Ranki, H; Rivera, C; Scozzafava, A; Supuran, CT; Voipio, J; Vullo, D | 1 |
Antel, J; Firnges, MA; Innocenti, A; Scozzafava, A; Supuran, CT; Wurl, M | 1 |
Casini, A; de Leval, X; Dogné, JM; Innocenti, A; Montero, JL; Scozzafava, A; Supuran, CT; Vullo, D; Winum, JY | 1 |
Cecchi, A; Fasolis, G; Gamberi, A; Montero, JL; Puccetti, L; Scozzafava, A; Supuran, CT; Winum, JY | 1 |
Chohan, ZH; Fasolis, G; Puccetti, L; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Cecchi, A; Hulikova, A; Montero, JL; Pastorek, J; Pastoreková, S; Scozzafava, A; Supuran, CT; Winum, JY | 1 |
Innocenti, A; Mastrolorenzo, A; Nishimori, I; Scozzafava, A; Supuran, CT; Vullo, D | 2 |
Bacciottini, L; Casini, A; Masini, E; Mincione, F; Scozzafava, A; Scrivanti, C; Starnotti, M; Supuran, CT; Vullo, D | 1 |
Gil, MJ; Innocenti, A; Martinez-Merino, V; Scozzafava, A; Supuran, CT; Villar, R; Vullo, D | 1 |
D'Ambrosio, K; De Simone, G; Di Fiore, A; Pedone, C; Scozzafava, A; Supuran, CT | 1 |
Minakuchi, T; Morimoto, K; Nishimori, I; Onishi, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Minakuchi, T; Morimoto, K; Nishimori, I; Onishi, S; Sano, S; Scozzafava, A; Supuran, CT; Takeuchi, H; Vullo, D | 1 |
Brzozowski, Z; Innocenti, A; Kornicka, A; Pomarnacka, E; Saczewski, F; Scozzafava, A; Supuran, CT; Sławiński, J | 1 |
De Simone, G; Di Fiore, A; Montero, JL; Pedone, C; Scozzafava, A; Supuran, CT; Vitale, RM; Winum, JY | 1 |
Bornaghi, LF; Houston, TA; Innocenti, A; Poulsen, SA; Supuran, CT; Wilkinson, BL | 1 |
Ciattini, S; El Cheikh, K; Innocenti, A; Montero, JL; Scozzafava, A; Supuran, CT; Temperini, C; Vullo, D; Winum, JY | 1 |
Bornaghi, LF; Houston, TA; Innocenti, A; Poulsen, SA; Supuran, CT; Vullo, D; Wilkinson, BL | 2 |
Minakuchi, T; Nishimori, I; Onishi, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Innocenti, A; Marques, S; Santos, MA; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Innocenti, A; Nencetti, S; Nuti, E; Orlandini, E; Rossello, A; Scozzafava, A; Supuran, CT | 1 |
Kohsaki, T; Minakuchi, T; Nishimori, I; Onishi, S; Scozzafava, A; Supuran, CT; Takeuchi, H; Vullo, D | 1 |
Alterio, V; De Simone, G; Monti, SM; Scozzafava, A; Supuran, CT | 1 |
Montero, JL; Regainia, Z; Scozzafava, A; Smaine, FZ; Supuran, CT; Vullo, D; Winum, JY | 1 |
Innocenti, A; Poulsen, SA; Salmon, AJ; Supuran, CT; Vullo, D; Williams, ML | 1 |
Cecchi, A; Minakuchi, T; Nishimori, I; Onishi, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Brzozowski, Z; Innocenti, A; Kornicka, A; Pomarnacka, E; Saczewski, F; Scozzafava, A; Supuran, CT; Sławiński, J; Temperini, C | 1 |
Innocenti, A; Poulsen, SA; Supuran, CT; Vullo, D; Wilkinson, BL | 1 |
Antel, J; De Simone, G; Di Fiore, A; Pedone, C; Scozzafava, A; Supuran, CT; Waldeck, H; Witte, A; Wurl, M | 1 |
Cecchi, A; Scozzafava, A; Supuran, CT; Temperini, C | 1 |
D'Ambrosio, K; De Simone, G; Dogné, JM; Innocenti, A; Masereel, B; Scozzafava, A; Supuran, CT; Vitale, RM | 1 |
Cecchi, A; Ciani, L; Montero, JL; Ristori, S; Scozzafava, A; Supuran, CT; Winum, JY | 1 |
Badawi, AM; Cecchi, A; Morsy, SM; Scozzafava, A; Supuran, CT | 1 |
Arslan, O; Aydin, M; Guler, OO; Innocenti, A; Isik, S; Kockar, F; Scozzafava, A; Supuran, CT | 1 |
Hilvo, M; Innocenti, A; Kulomaa, MS; Parkkila, S; Salzano, AM; Scaloni, A; Scozzafava, A; Supuran, CT | 1 |
Eroğlu, E; Oltulu, O; Yaşar, MM | 1 |
Minakuchi, T; Nishimori, I; Scozzafava, A; Supuran, CT; Vullo, D | 2 |
Innocenti, A; Minakuchi, T; Nishimori, I; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Balaban, AT; Güzel, O; Maresca, A; Salman, A; Scozzafava, A; Supuran, CT | 1 |
Hall, RA; Innocenti, A; Mühlschlegel, FA; Schlicker, C; Scozzafava, A; Steegborn, C; Supuran, CT | 1 |
Bertucci, A; Innocenti, A; Scozzafava, A; Supuran, CT; Tambutté, S; Zoccola, D | 2 |
Carta, F; Maresca, A; Pothen, B; Singh, V; Supuran, CT; Tiwari, M | 1 |
Carta, F; Covarrubias, AS; Jones, TA; Maresca, A; Mowbray, SL; Supuran, CT | 1 |
Joseph, P; Köhler, S; Minakuchi, T; Montero, JL; Nishimori, I; Ouahrani-Bettache, S; Scozzafava, A; Supuran, CT; Turtaut, F; Vullo, D; Winum, JY | 1 |
Brzozowski, Z; Innocenti, A; Saczewski, F; Supuran, CT; Sławiński, J | 1 |
Brzozowski, Z; Innocenti, A; Supuran, CT; Sławiński, J | 1 |
Joseph, P; Köhler, S; Minakuchi, T; Montero, JL; Nishimori, I; Ouahrani-Bettache, S; Scozzafava, A; Supuran, CT; Vullo, D; Winum, JY | 1 |
Maresca, A; Supuran, CT | 1 |
Cincinelli, A; Innocenti, A; Martellini, T; Scozzafava, A; Supuran, CT | 1 |
Aggarwal, M; Biswas, S; Güzel, Ö; McKenna, R; Scozzafava, A; Supuran, CT | 1 |
Brzozowski, Z; Gdaniec, M; Innocenti, A; Supuran, CT; Sławiński, J | 1 |
Jackson, DJ; Ohradanova, A; Pastorek, J; Pastorekova, S; Supuran, CT; Vullo, D; Wörheide, G | 1 |
Hewitson, KS; Mastrolorenzo, A; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Capasso, C; Carginale, V; Luca, VD; Rossi, M; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Brzozowski, Z; Supuran, CT; Sławiński, J; Vullo, D | 1 |
Capasso, C; Carginale, V; De Luca, V; Del Prete, S; Isik, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Capaci Rodrigues, G; Capasso, C; Pan, P; Parkkila, S; Scozzafava, A; Supuran, CT; Tolvanen, ME; Vermelho, AB | 1 |
Capasso, C; Leewattanapasuk, W; Mastrolorenzo, A; Mühlschlegel, FA; Supuran, CT; Vullo, D | 1 |
Capasso, C; Corte-Real, S; Pan, P; Parkkila, S; Rodrigues, Ide A; Salonen, T; Supuran, CT; Syrjänen, L; Vermelho, AB; Vullo, D | 1 |
Chojnacki, J; Pogorzelska, A; Supuran, CT; Sławiński, J; Vullo, D; Żołnowska, B | 1 |
Alothman, Z; Capasso, C; De Luca, V; Del Prete, S; Osman, SM; Scozzafava, A; Supuran, CT; Vullo, D | 2 |
Barboiu, M; Cristian, A; Nasr, G; Supuran, CT; Vullo, D; Winum, JY | 1 |
Capasso, C; Minakuchi, T; Nishimori, I; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Brożewicz, K; Pogorzelska, A; Supuran, CT; Sławiński, J; Vullo, D; Żołnowska, B | 1 |
Brzozowski, Z; Pogorzelska, A; Supuran, CT; Szafrański, K; Sławiński, J; Vullo, D; Żołnowska, B | 1 |
AlOthman, Z; Capasso, C; Osman, SM; Prete, SD; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
Andrews, KT; Capasso, C; Del Prete, S; Fisher, GM; Poulsen, SA; Supuran, CT; Vullo, D | 1 |
Capasso, C; Carginale, V; De Luca, V; Del Prete, S; Scozzafava, A; Supuran, CT; Vullo, D | 2 |
Kuuslahti, M; Parkkila, S; Supuran, CT; Syrjänen, L; Tolvanen, M; Vullo, D | 1 |
Ceruso, M; Durgun, M; Supuran, CT; Turkmen, H | 1 |
Capasso, C; Dedeoglu, N; DeLuca, V; Isik, S; Kockar, F; Supuran, CT; Yildirim, H | 1 |
Bhatt, A; Mahon, BP; McKenna, R; Supuran, CT; Vullo, D | 1 |
AlOthman, Z; Capasso, C; Carginale, V; De Luca, V; Del Prete, S; Osman, SM; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
AlOthman, Z; Capasso, C; Carginale, V; De Luca, V; Del Prete, S; Ferraroni, M; Osman, SM; Supuran, CT; Vullo, D | 1 |
Aşık, A; Beldüz, AO; Çanakçı, S; Çolak, DN; Eminoğlu, A; Supuran, CT; Vullo, D | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
AlOthman, Z; Capasso, C; Carginale, V; De Luca, V; Del Prete, S; Osman, SM; Supuran, CT; Vullo, D | 2 |
Cadoni, R; Carcelli, M; Dallocchio, R; Dessì, A; Iaccarino, C; Lomelino, C; Mahon, BP; McKenna, R; Pala, N; Rassu, M; Rogolino, D; Sanna, V; Sechi, M; Supuran, CT; Vullo, D | 1 |
Gelatt, KN; Gum, G; Gwin, RM; Williams, LW | 1 |
Barnikol, WK; Diether, K | 1 |
Beall, OV; Lichter, PR; Newman, LP; Wheeler, NC | 1 |
Barrett, RJ; Gathright, CE; Nolan, JC; Radvany, CH; Sancilio, LF | 1 |
Bagby, GC; Dreis, MW; Fraunfelder, FT; Meyer, SM | 1 |
Lotti, VJ; Stone, CA; Torchiana, ML | 1 |
Landauer, W; Wakasugi, N | 1 |
Maren, TH; Sanders, E | 2 |
Kanski, JJ | 1 |
Nass, JU; Nuskovski, M; Thieme, H; Wiederholt, M | 1 |
DEGRAFF, AC; LYON, AF | 1 |
Baillie, DL; Borrel, C; Bulst, S; Giacomotto, J; Johnsen, B; Lochmüller, H; Pertl, C; Ségalat, L; Thirion, C; Walter, MC | 1 |
Calzolaro, S; Camerino, GM; Cannone, G; Conte Camerino, D; Dinardo, MM; Latorre, R; Mele, A; Tricarico, D | 1 |
Reviews
2 review(s) available for methazolamide and dichlorphenamide
Article | Year |
---|---|
Carbonic anhydrases as targets for medicinal chemistry.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Isoenzymes; Models, Molecular; Tissue Distribution | 2007 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Trials
1 trial(s) available for methazolamide and dichlorphenamide
Article | Year |
---|---|
Patient tolerance to carbonic anhydrase inhibitors.
Topics: Acetazolamide; Anorexia; Carbonic Anhydrase Inhibitors; Confusion; Dichlorphenamide; Drug Evaluation; Ethoxzolamide; Fatigue; Glaucoma; Humans; Intraocular Pressure; Methazolamide | 1978 |
Other Studies
125 other study(ies) available for methazolamide and dichlorphenamide
Article | Year |
---|---|
Topically active carbonic anhydrase inhibitors. 2. Benzo[b]thiophenesulfonamide derivatives with ocular hypotensive activity.
Topics: Animals; Carbonic Anhydrase Inhibitors; Chemical Phenomena; Chemistry; Glaucoma; Guinea Pigs; Intraocular Pressure; Ocular Hypertension; Rabbits; Skin; Sulfonamides; Thiophenes | 1989 |
Topically active carbonic anhydrase inhibitors. 1. O-acyl derivatives of 6-hydroxybenzothiazole-2-sulfonamide.
Topics: Animals; Benzothiazoles; Carbonic Anhydrase Inhibitors; Chemical Phenomena; Chemistry; Cornea; Ethoxzolamide; Guinea Pigs; Humans; Intraocular Pressure; Ophthalmic Solutions; Prodrugs; Rabbits; Thiazoles | 1989 |
Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action.
Topics: Administration, Topical; Animals; Aqueous Humor; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cattle; Glaucoma; Humans; Intraocular Pressure; Isoenzymes; Lung; Rabbits; Solubility; Structure-Activity Relationship; Sulfonamides; Tissue Distribution; Uvea | 2000 |
Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects.
Topics: Animals; Carbonic Anhydrase Inhibitors; Cornea; Eye; Glaucoma; Hydrogen-Ion Concentration; Intraocular Pressure; Ophthalmic Solutions; Rabbits; Solubility; Structure-Activity Relationship; Sulfonamides; Thiourea; Tissue Distribution; Water | 2000 |
Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Chelating Agents; Chloroform; Chromatography, High Pressure Liquid; Cornea; DNA, Complementary; Edetic Acid; Enzyme Inhibitors; Escherichia coli; Glaucoma; Humans; Hydrogen-Ion Concentration; Imino Acids; Kinetics; Male; Models, Chemical; Nitrilotriacetic Acid; Pentetic Acid; Pressure; Rabbits; Sulfonamides; Temperature; Time Factors; Ultraviolet Rays; Water | 2002 |
Carbonic anhydrase inhibitors. Preparation of potent sulfonamides inhibitors incorporating bile acid tails.
Topics: Bile Acids and Salts; Carbonic Anhydrase Inhibitors; Sulfonamides | 2002 |
Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation.
Topics: Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Crystallography, X-Ray; Databases, Factual; Humans; Isoenzymes; Ligands; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship | 2002 |
Carbonic anhydrase inhibitors: inhibition of cytosolic isozymes I and II with sulfamide derivatives.
Topics: Amines; Binding Sites; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Cytosol; Humans; Models, Molecular; Structure-Activity Relationship; Sulfonamides | 2003 |
Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.
Topics: Animals; Binding Sites; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Cattle; Crystallography, X-Ray; Fructose; Humans; Hydrogen Bonding; Models, Molecular; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids; Topiramate; Zinc | 2003 |
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
Topics: Animals; Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cattle; Heterocyclic Compounds; Humans; Hydrocarbons, Aromatic; Isoenzymes; Kinetics; Neoplasm Proteins; Neoplasms; Structure-Activity Relationship; Sulfonamides | 2003 |
Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Benzene Derivatives; Bromine; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase IV; Carbonic Anhydrase IX; Carbonic Anhydrases; Chlorine; Enzyme Inhibitors; Humans; Iodine; Neoplasm Proteins; Structure-Activity Relationship; Sulfanilamides; Sulfonamides | 2003 |
Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Glaucoma; Hypertension; Intraocular Pressure; Male; Monosaccharides; Rabbits; Sulfanilamides | 2004 |
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride.
Topics: Antipsychotic Agents; Binding Sites; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Crystallography, X-Ray; Humans; Isoenzymes; Sulpiride | 2004 |
Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
Topics: Animals; Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Celecoxib; Crystallography, X-Ray; Cyclooxygenase 2; Intraocular Pressure; Isoenzymes; Isoxazoles; Kinetics; Lactones; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rabbits; Structure-Activity Relationship; Sulfonamides; Sulfones | 2004 |
Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
Topics: Animals; Benzene Derivatives; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase V; Coumarins; Mice; Mitochondria; Structure-Activity Relationship; Sulfonamides; Thiadiazoles | 2004 |
Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Humans; Isoenzymes; Molecular Structure; Neoplasm Proteins; Sulfonamides | 2004 |
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
Topics: Carbonic Anhydrase Inhibitors; Fluorine; Isoenzymes; Sulfonamides | 2004 |
Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX.
Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Erythrocyte Membrane; Humans; In Vitro Techniques; Isoenzymes; Permeability; Pyridinium Compounds; Structure-Activity Relationship; Sulfonamides | 2004 |
Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
Topics: Administration, Topical; Animals; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Fluorine; Glaucoma; Heterocyclic Compounds; Intraocular Pressure; Rabbits; Structure-Activity Relationship; Sulfonamides | 2004 |
Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.
Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Isoenzymes; Quantitative Structure-Activity Relationship; Sulfonamides | 2004 |
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
Topics: Amino Acid Sequence; Animals; Carbonic Anhydrase Inhibitors; Cytosol; Drug Design; Humans; Hydrogen-Ion Concentration; Isoenzymes; Kinetics; Molecular Sequence Data; Neoplasms; Rats; Structure-Activity Relationship; Sulfonamides | 2004 |
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cytosol; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Sulfonamides; Triazines | 2004 |
Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library.
Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Combinatorial Chemistry Techniques; Databases, Factual; Humans; Structure-Activity Relationship; Sulfonamides; Thiourea | 2004 |
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
Topics: Benzolamide; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cytosol; Humans; Neoplasms; Nerve Tissue Proteins; Sulfonamides | 2004 |
Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.
Topics: Archaea; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Isoenzymes; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2004 |
Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.
Topics: Acetazolamide; Amines; Biomarkers, Tumor; Carbonic Anhydrase Inhibitors; Catalysis; Cytosol; Heterocyclic Compounds; Humans; Isoenzymes; Morpholines; Piperazine; Piperazines; Piperidines; Structure-Activity Relationship; Sulfanilamide; Sulfanilamides | 2005 |
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates.
Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cytosol; Humans; Isoenzymes; Neoplasm Proteins; Structure-Activity Relationship; Sulfonic Acids | 2005 |
Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
Topics: Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Drug Design; Glaucoma; Humans; Isoenzymes; Structure-Activity Relationship; Sulfonamides | 2005 |
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Topics: Anticonvulsants; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Heterocyclic Compounds; Humans; Hydrocarbons, Aromatic; Isoenzymes; Protein Subunits; Structure-Activity Relationship; Sulfonamides | 2005 |
Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Cattle; Dose-Response Relationship, Drug; Humans; Isoenzymes; Kinetics; Membrane Proteins; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids | 2005 |
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Membrane; Cytosol; Hydrazines; Isocyanates; Isoenzymes; Structure-Activity Relationship; Sulfonamides | 2005 |
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Catalytic Domain; Cytosol; Humans; Kinetics; Neoplasms; Structure-Activity Relationship; Sulfonamides; Urea | 2005 |
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Membrane; Cytosol; Humans; Isoenzymes; Molecular Structure; Structure-Activity Relationship; Sulfonamides; Triazines | 2005 |
Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Membrane; Chromones; Cytosol; Humans; Isoenzymes; Molecular Structure; Nerve Tissue Proteins; Schiff Bases; Structure-Activity Relationship; Sulfonamides; Zinc Compounds | 2005 |
Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
Topics: Animals; Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Catalytic Domain; Cell Hypoxia; Cell Line; Cell Membrane Permeability; Dogs; Erythrocyte Membrane; Extracellular Fluid; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Isoenzymes; Mutation; Sequence Deletion; Sulfonamides | 2005 |
Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Fructose; Humans; Kinetics; Membrane Proteins; Protein Binding; Structure-Activity Relationship; Sulfonamides; Topiramate | 2005 |
Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
Topics: Animals; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Disease Models, Animal; Drug Design; Glaucoma; Intraocular Pressure; Rabbits; Structure-Activity Relationship; Sulfonamides | 2005 |
Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with benzo[b]thiophene 1,1-dioxide sulfonamides.
Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cytosol; Humans; Neoplasm Proteins; Structure-Activity Relationship | 2005 |
Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Topics: Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Celecoxib; Crystallography, X-Ray; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Humans; Isoenzymes; Isoxazoles; Models, Molecular; Molecular Structure; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Pyrazoles; Structure-Activity Relationship; Sulfonamides; Topoisomerase II Inhibitors | 2006 |
Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase V; Catalysis; Cloning, Molecular; Humans; Isoenzymes; Kinetics; Mitochondria; Molecular Sequence Data; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids | 2005 |
Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Topics: Benzenesulfonamides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Structure-Activity Relationship; Sulfonamides | 2006 |
Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; DNA, Bacterial; Gastric Mucosa; Gastritis; Helicobacter pylori; Humans; Molecular Sequence Data; Polymorphism, Genetic; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Sulfonic Acids | 2006 |
Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors.
Topics: Carbonic Anhydrase Inhibitors; Cell Hypoxia; Cell Membrane; Cytosol; Humans; Isoenzymes; Molecular Structure; Neoplasms; Sulfonamides; Water | 2006 |
Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX.
Topics: Antigens, Neoplasm; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Crystallography, X-Ray; Disulfides; Enzyme Activation; Humans; Hydrogen Bonding; Hypoxia; Isoenzymes; Models, Molecular; Molecular Structure; Neoplasms; Prodrugs; Protein Binding; Structure-Activity Relationship; Sulfhydryl Compounds; Sulfonamides | 2006 |
A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing".
Topics: Benzene Derivatives; Carbohydrate Sequence; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Glycosylation; Indicators and Reagents; Isoenzymes; Molecular Sequence Data; Sulfonamides | 2006 |
Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue.
Topics: Alanine; Anticonvulsants; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Crystallography, X-Ray; Drug Design; Fructose; Hydrogen Bonding; Isoenzymes; Models, Molecular; Molecular Structure; Protein Binding; Structure-Activity Relationship; Sulfonamides; Topiramate | 2006 |
Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides.
Topics: Carbonic Anhydrase Inhibitors; Cyclization; Glycoconjugates; Humans; Isoenzymes; Membranes; Phenolsulfonphthalein; Recombinant Proteins; Sulfonamides | 2007 |
Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalysis; Cloning, Molecular; DNA; Humans; Isoenzymes; Molecular Sequence Data; Protein Subunits; Sequence Homology, Amino Acid; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids | 2007 |
Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties.
Topics: Carbonic Anhydrase Inhibitors; Cell Membrane; Cytosol; Humans; Hydroxamic Acids; Indicators and Reagents; Isoenzymes; Neoplasms; Structure-Activity Relationship; Sulfonamides | 2007 |
Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.
Topics: Animals; Carbonic Anhydrase I; Carbonic Anhydrase II; Cytosol; Enzyme Inhibitors; Humans; Hydroxamic Acids; Isoenzymes; Matrix Metalloproteinase Inhibitors; Mice; Molecular Structure; Multiple Myeloma; Structure-Activity Relationship; Sulfonic Acids; Tumor Cells, Cultured | 2007 |
Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
Topics: Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase III; Carbonic Anhydrase Inhibitors; Galactosides; Glycosides; Isoenzymes; Structure-Activity Relationship; Sulfonamides; Triazoles | 2007 |
Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Chemistry, Pharmaceutical; Cloning, Molecular; Drug Design; Enzyme Inhibitors; Helicobacter pylori; Humans; Molecular Sequence Data; Recombinant Proteins; Sequence Homology, Amino Acid; Stomach Neoplasms; Stomach Ulcer; Sulfonamides | 2007 |
Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides--solution and crystallographic studies.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Crystallography, X-Ray; Hydrogen Bonding; Isoenzymes; Models, Molecular; Sulfonamides | 2007 |
Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides.
Topics: Carbonic Anhydrase Inhibitors; Isoenzymes; Sulfonamides | 2007 |
Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing an organometallic moiety.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Isoenzymes; Magnetic Resonance Spectroscopy; Organometallic Compounds; Substrate Specificity; Sulfonamides | 2007 |
Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
Topics: Amino Acid Sequence; Carbonic Anhydrase III; Carbonic Anhydrase Inhibitors; Cloning, Molecular; Cytosol; Enzyme Activation; Humans; Isoenzymes; Kinetics; Molecular Sequence Data; Recombinant Proteins; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids | 2007 |
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Topics: Benzenesulfonamides; Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cytosol; Humans; Hydrocarbons, Chlorinated; Isoenzymes; Methylation; Models, Molecular; Molecular Sequence Data; Molecular Structure; Neoplasms; Protein Folding; Sequence Alignment; Structure-Activity Relationship; Sulfhydryl Compounds; Sulfonamides | 2008 |
Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides.
Topics: Antigens, Neoplasm; Benzene Derivatives; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Glycosides; Humans; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Triazoles | 2008 |
Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors.
Topics: Animals; Binding Sites; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Catalysis; Crystallography, X-Ray; Ethoxzolamide; Glutamine; Humans; Isoenzymes; Mice; Models, Molecular; Molecular Structure; Protein Binding; Threonine | 2008 |
Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Computer Simulation; Crystallography, X-Ray; Humans; Indapamide; Isoenzymes; Mice; Models, Molecular; Molecular Structure | 2008 |
Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.
Topics: Amino Acid Sequence; Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Conserved Sequence; Crystallography, X-Ray; Humans; Isoenzymes; Models, Molecular; Molecular Sequence Data; Neoplasms; Nitro Compounds; Structure-Activity Relationship; Sulfonamides | 2008 |
Carbonic anhydrase inhibitors: design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes.
Topics: Antigens, Neoplasm; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Membrane; Cyclic N-Oxides; Cytosol; Drug Design; Drug Evaluation, Preclinical; Free Radicals; Humans; Isoenzymes; Molecular Structure; Recombinant Proteins; Spin Labels; Stereoisomerism; Structure-Activity Relationship; Sulfonamides | 2008 |
Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; HCT116 Cells; Humans; Isoenzymes; Lung Neoplasms; Sulfonamides | 2009 |
Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
Topics: Amino Acid Sequence; Antifungal Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Kinetics; Molecular Sequence Data; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Sulfonamides; Sulfonic Acids | 2009 |
Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Isoenzymes; Kidney; Mice; Protein Processing, Post-Translational | 2009 |
A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method.
Topics: Artificial Intelligence; Carbonic Anhydrase II; Computer Simulation; Isoenzymes; Models, Chemical; Quantitative Structure-Activity Relationship; Sulfonamides | 2009 |
Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalysis; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Humans; Molecular Sequence Data; Mycobacterium tuberculosis; Recombinant Proteins; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids | 2009 |
Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
Topics: Amino Acid Sequence; Biocatalysis; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Molecular Sequence Data; Mycobacterium tuberculosis; Sulfonamides; Sulfonic Acids | 2009 |
Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Humans; Pyridinium Compounds; Sulfonamides | 2009 |
Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.
Topics: Amino Acid Sequence; Antifungal Agents; Bacterial Proteins; Candida albicans; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cryptococcus neoformans; Helicobacter pylori; Humans; Models, Molecular; Molecular Sequence Data; Protein Binding; Protein Conformation; Sequence Alignment; Structure-Activity Relationship; Sulfonamides | 2009 |
Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
Topics: Amino Acid Sequence; Animals; Anthozoa; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Molecular Sequence Data; Molecular Structure; Recombinant Proteins; Sequence Alignment; Sulfonamides | 2009 |
Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.
Topics: Azo Compounds; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coloring Agents; Humans; Sulfanilamide; Sulfanilamides | 2009 |
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalytic Domain; Drug Design; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2009 |
Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.
Topics: Amino Acid Sequence; Animals; Base Sequence; Brucella suis; Brucellosis; Carbonic Anhydrases; Cloning, Molecular; DNA, Bacterial; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Sequence Alignment; Sequence Analysis, DNA; Structure-Activity Relationship; Sulfonamides | 2010 |
Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cytosol; Humans; Isoenzymes; Sulfonamides | 2010 |
Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Membrane; Cytosol; Humans; Isoenzymes; Neoplasms; Stereoisomerism; Substrate Specificity; Sulfonamides | 2010 |
Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
Topics: Animals; Anions; Anthozoa; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Structure-Activity Relationship; Sulfonamides | 2011 |
A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
Topics: Anti-Bacterial Agents; Brucella suis; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Drug Design; Drug Discovery; Inhibitory Concentration 50; Kinetics; Sulfonamides; Sulfonic Acids | 2011 |
(R)-/(S)-10-camphorsulfonyl-substituted aromatic/heterocyclic sulfonamides selectively inhibit mitochondrial over cytosolic carbonic anhydrases.
Topics: Animals; Camphor; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cytosol; Enzyme Assays; Heterocyclic Compounds; Humans; Mitochondria; Molecular Structure; Stereoisomerism; Sulfonamides | 2011 |
Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii.
Topics: Animals; Anions; Antarctic Regions; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Protein Isoforms; Seals, Earless; Sulfonamides | 2011 |
Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
Topics: Acetamides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Catalytic Domain; Crystallography, X-Ray; Cytosol; Enzyme Activation; Humans; Isoenzymes; Models, Molecular; Molecular Structure; Protein Binding; Structure-Activity Relationship; Sulfonamides | 2011 |
Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.
Topics: Anti-Bacterial Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Salmonella Infections; Salmonella typhimurium; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids | 2011 |
Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
Topics: Carbonic Anhydrase Inhibitors; Cytosol; Humans; Isoenzymes; Magnetic Resonance Spectroscopy; Models, Molecular; Sulfonamides | 2011 |
Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.
Topics: Amino Acid Sequence; Animals; Carbonic Anhydrases; Cloning, Molecular; Fossils; Humans; Molecular Sequence Data; Porifera; Protein Binding; Sequence Alignment; Sulfonamides; Sulfonic Acids | 2012 |
Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Dermatomycoses; Fungal Proteins; Humans; Isoenzymes; Malassezia; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Recombinant Fusion Proteins; Scalp Dermatoses; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids | 2012 |
The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides.
Topics: Amino Acid Sequence; Bacteria; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Protein Binding; Recombinant Proteins; Sequence Alignment; Sulfonamides | 2013 |
Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Isoenzymes; Molecular Structure; Pyridines; Stereoisomerism; Structure-Activity Relationship; Sulfonamides | 2012 |
DNA cloning, characterization, and inhibition studies of an α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
Topics: Amino Acid Sequence; Biocatalysis; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; DNA; Electrophoresis, Polyacrylamide Gel; Molecular Sequence Data; Phylogeny; Sequence Homology, Amino Acid; Vibrio cholerae | 2012 |
Cloning, characterization, and sulfonamide and thiol inhibition studies of an α-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Chagas Disease; Cloning, Molecular; Humans; Molecular Sequence Data; Phylogeny; Protozoan Proteins; Structure-Activity Relationship; Sulfhydryl Compounds; Sulfonamides; Thiadiazoles; Trypanocidal Agents; Trypanosoma cruzi | 2013 |
Carbonic anhydrase inhibitors: inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides.
Topics: Acetazolamide; Amino Acid Sequence; Antifungal Agents; Candida glabrata; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Protein Binding; Sequence Alignment; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids | 2013 |
Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis.
Topics: Amino Acid Sequence; Antiprotozoal Agents; Biocatalysis; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Leishmania infantum; Leishmaniasis; Molecular Sequence Data | 2013 |
Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associat
Topics: Antigens, Neoplasm; Antineoplastic Agents; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Line, Tumor; Cytosol; Guanidines; Humans; Isoenzymes; Models, Molecular; Neoplasms; Structure-Activity Relationship | 2014 |
Sulfonamide inhibition studies of the δ-carbonic anhydrase from the diatom Thalassiosira weissflogii.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Diatoms; Dose-Response Relationship, Drug; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2014 |
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Molecular Structure; Porphyromonas gingivalis; Structure-Activity Relationship; Sulfonamides | 2014 |
Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff's bases incorporating sulfonamide, carboxylate and carboxymethyl moieties.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carboxylic Acids; Dose-Response Relationship, Drug; Humans; Isoenzymes; Molecular Structure; Schiff Bases; Structure-Activity Relationship; Sulfonamides | 2014 |
Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Legionella pneumophila; Molecular Sequence Data; Molecular Structure; Sequence Alignment; Structure-Activity Relationship; Sulfonamides | 2014 |
Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Membrane; Dose-Response Relationship, Drug; Humans; Isoenzymes; Molecular Structure; Neoplasms; Structure-Activity Relationship; Sulfonamides | 2014 |
Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Topics: Benzenesulfonamides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Isoenzymes; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2014 |
Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the β-class (PgiCAb) versus the γ-class (PgiCA) enzymes.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Molecular Sequence Data; Molecular Structure; Phylogeny; Porphyromonas gingivalis; Structure-Activity Relationship; Sulfonamides | 2014 |
Sulfonamide inhibition studies of the η-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum.
Topics: Antimalarials; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Plasmodium falciparum; Structure-Activity Relationship; Sulfonamides | 2015 |
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Molecular Sequence Data; Nostoc commune; Sequence Alignment; Sulfanilamide; Sulfanilamides; Sulfonamides; Thiazines; Thiophenes | 2015 |
The β-carbonic anhydrase from the malaria mosquito Anopheles gambiae is highly inhibited by sulfonamides.
Topics: Amino Acid Sequence; Animals; Anopheles; Baculoviridae; Bicarbonates; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Gene Expression; High-Throughput Screening Assays; Insect Proteins; Insecticides; Kinetics; Molecular Sequence Data; Phylogeny; Protons; Recombinant Proteins; Sequence Alignment; Sf9 Cells; Spodoptera; Sulfanilamides | 2015 |
Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Imines; Isoenzymes; Molecular Structure; Sulfonamides | 2015 |
Sulfonamide inhibition study of the β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Molecular Sequence Data; Molecular Structure; Phylogeny; Streptococcus mutans; Sulfonamides | 2015 |
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
Topics: Acclimatization; Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cold Temperature; Humans; Molecular Sequence Data; Phylogeny; Pseudoalteromonas; Sequence Alignment; Sulfonamides | 2015 |
Sulfonamide inhibition studies of the α-carbonic anhydrase from the gammaproteobacterium Thiomicrospira crunogena XCL-2, TcruCA.
Topics: Anti-Bacterial Agents; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Gammaproteobacteria; Molecular Docking Simulation; Sulfonamides | 2016 |
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
Topics: Alteromonadaceae; Anti-Bacterial Agents; Bacterial Proteins; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Kinetics; Phylogeny; Protein Binding; Sulfanilamide; Sulfanilamides | 2016 |
Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
Topics: Amino Acid Sequence; Base Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cholera; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Sequence Data; Sulfonamides; Vibrio cholerae | 2016 |
Sulfonamide inhibition studies of the β-carbonic anhydrase from the newly discovered bacterium Enterobacter sp. B13.
Topics: Acetazolamide; Benzenesulfonamides; Carbonic Anhydrase I; Carbonic Anhydrase Inhibitors; Enterobacter; Enterobacteriaceae Infections; Humans; Methazolamide; Structure-Activity Relationship; Sulfonamides | 2016 |
Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship; Sulfonamides; Vibrio cholerae | 2016 |
Cloning, expression, purification and sulfonamide inhibition profile of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum.
Topics: Amino Acid Sequence; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; Humans; Kinetics; Molecular Sequence Data; Plasmodium falciparum; Protein Isoforms; Protein Structure, Tertiary; Recombinant Proteins; Sequence Alignment; Structure-Activity Relationship; Sulfonamides | 2016 |
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors.
Topics: | 2017 |
Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles.
Topics: Acetazolamide; Administration, Oral; Animals; Carbonic Anhydrase Inhibitors; Dichlorphenamide; Dog Diseases; Dogs; Ethoxzolamide; Glaucoma; Intraocular Pressure; Methazolamide; Time Factors | 1979 |
[The broncholytic effect of carboanhydrase inhibitors in subjects with healthy lungs (author's transl)].
Topics: Acetazolamide; Adult; Bronchi; Carbonic Anhydrase Inhibitors; Dichlorphenamide; Humans; Lung Volume Measurements; Male; Methazolamide; Time Factors | 1979 |
Carbonic anhydrase inhibitors are antiarthritic in the rat.
Topics: Acetazolamide; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carbonic Anhydrase Inhibitors; Carrageenan; Dichlorphenamide; Edema; Ethoxzolamide; Female; Indomethacin; Methazolamide; Rats | 1991 |
Hematologic reactions to carbonic anhydrase inhibitors.
Topics: Acetazolamide; Agranulocytosis; Anemia, Aplastic; Carbonic Anhydrase Inhibitors; Dichlorphenamide; Glaucoma; Humans; Leukopenia; Methazolamide; Pancytopenia; Thrombocytopenia | 1985 |
The anticonvulsant effect of carbonic anhydrase inhibitors in mice--a noradrenergic mechanism of action.
Topics: Acetazolamide; Amino Acids; Animals; Anticonvulsants; Carbonic Anhydrase Inhibitors; Carboxy-Lyases; Dichlorphenamide; Dihydroxyphenylalanine; Disulfiram; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Electroshock; Female; Hydrazines; Methazolamide; Methyldopa; Mice; Monoamine Oxidase Inhibitors; Picolinic Acids; Reserpine | 1973 |
Teratological studies with sulphonamides and their implications.
Topics: Abnormalities, Drug-Induced; Adenine Nucleotides; Animals; Carbonic Anhydrase Inhibitors; Chick Embryo; Chloramines; Dichlorphenamide; Drug Synergism; Folic Acid; Methazolamide; NAD; Pyridines; Sulfanilamides; Sulfonamides; Time Factors | 1968 |
Inhibition of carbonic anhydrase in Neisseria: effects on enzyme activity and growth.
Topics: Acetazolamide; Bicarbonates; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Chlorothiazide; Dichlorphenamide; Erythrocytes; Methazolamide; Neisseria; Sulfadiazine; Sulfanilamides | 1967 |
Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Dichlorphenamide; Glaucoma; Humans; Intraocular Pressure; Methazolamide | 1968 |
Diuretics found effective against meningococci?
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Chlorothiazide; Dichlorphenamide; Humans; Hydrochlorothiazide; Methazolamide; Neisseria; Sulfadiazine; Sulfanilamides; Sulfonamides | 1967 |
The effects of the carbonic anhydrase inhibitors methazolamide, diclofenamide and dorzolamide on trabecular meshwork and ciliary muscle contractility.
Topics: Animals; Carbonic Anhydrase Inhibitors; Cattle; Ciliary Body; Dichlorphenamide; Methazolamide; Muscle Contraction; Sulfonamides; Thiophenes; Trabecular Meshwork | 1999 |
DIURETIC THERAPY. I.
Topics: Acetazolamide; Aminophylline; Ammonium Chloride; Dichlorphenamide; Diuretics; Heart Failure; Humans; Imidazoles; Lysine; Mannitol; Methazolamide; Pharmacology; Theobromine; Toxicology; Urea | 1964 |
Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy.
Topics: Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dichlorphenamide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Dystrophin; Humans; Methazolamide; Mice; Mice, Inbred mdx; Motor Activity; Muscle Contraction; Muscle, Skeletal; Muscular Dystrophy, Animal; RNA Interference; Time Factors | 2009 |
Emerging role of calcium-activated potassium channel in the regulation of cell viability following potassium ions challenge in HEK293 cells and pharmacological modulation.
Topics: Bendroflumethiazide; Cell Line; Cell Survival; Charybdotoxin; Dichlorphenamide; Ethoxzolamide; Humans; Methazolamide; Peptides; Potassium; Potassium Channels, Calcium-Activated; Tetraethylammonium | 2013 |